Article
VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.
Clinical orthopaedics and related research - 1 Jul 2009
González Della Valle Alejandro, Khakharia Saurabh, Glueck Charles J, Taveras Nicole, Wang Ping, Fontaine Robert N, Salvati Eduardo A
Abstract excerpt
UNLABELLED: Warfarin dosing algorithms do not account for genetic mutations that can affect anticoagulation response. We retrospectively assessed to what extent the VKORC1 variant genotype would alter the likelihood of being a hyperresponder or hyporesponder to warfarin in patients undergoing total joint arthroplasty. We used the international normalized ratio (INR) on the third postoperative day of 3.0 or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
